211 related articles for article (PubMed ID: 25055039)
1. The cost-effectiveness of different feeding patterns combined with prompt treatments for preventing mother-to-child HIV transmission in South Africa: estimates from simulation modeling.
Yu W; Li C; Fu X; Cui Z; Liu X; Fan L; Zhang G; Ma J
PLoS One; 2014; 9(7):e102872. PubMed ID: 25055039
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
[TBL] [Abstract][Full Text] [Related]
3. The costs and benefits of Option B+ for the prevention of mother-to-child transmission of HIV.
Gopalappa C; Stover J; Shaffer N; Mahy M
AIDS; 2014 Jan; 28 Suppl 1():S5-14. PubMed ID: 24468947
[TBL] [Abstract][Full Text] [Related]
4. Cost and cost-effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV-positive pregnant and breastfeeding women in Swaziland.
Cunnama L; Abrams EJ; Myer L; Gachuhi A; Dlamini N; Hlophe T; Kikuvi J; Langwenya N; Mthethwa S; Mudonhi D; Nhlabatsi B; Nuwagaba-Biribonwoha H; Okello V; Sahabo R; Zerbe A; Sinanovic E
Trop Med Int Health; 2018 Sep; 23(9):950-959. PubMed ID: 29956426
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of option B plus for prevention of mother-to-child transmission of HIV in resource-limited countries: evidence from Kumasi, Ghana.
VanDeusen A; Paintsil E; Agyarko-Poku T; Long EF
BMC Infect Dis; 2015 Mar; 15():130. PubMed ID: 25887574
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of infant feeding modalities for virally suppressed mothers in Canada living with HIV.
Keshmiri R; Coyte PC; Laporte A; Sheth PM; Loutfy M
Medicine (Baltimore); 2019 Jun; 98(23):e15841. PubMed ID: 31169687
[TBL] [Abstract][Full Text] [Related]
7. Provider- and patient-level costs associated with providing antiretroviral therapy during the postpartum phase to women living with HIV in South Africa: A cost comparison of three postpartum models of care.
Cunnama L; Abrams EJ; Myer L; Phillips TK; Dugdale CM; Ciaranello AL; Zerbe A; Iyun V; MacQuilkan K; Daries V; Sinanovic E
Trop Med Int Health; 2020 Dec; 25(12):1553-1567. PubMed ID: 32959434
[TBL] [Abstract][Full Text] [Related]
8. Prevention of mother-to-child transmission of HIV: cost-effectiveness of antiretroviral regimens and feeding options in Rwanda.
Binagwaho A; Pegurri E; Drobac PC; Mugwaneza P; Stulac SN; Wagner CM; Karema C; Tsague L
PLoS One; 2013; 8(2):e54180. PubMed ID: 23437040
[TBL] [Abstract][Full Text] [Related]
9. Health outcomes and cost impact of the new WHO 2013 guidelines on prevention of mother-to-child transmission of HIV in Zambia.
Ishikawa N; Shimbo T; Miyano S; Sikazwe I; Mwango A; Ghidinelli MN; Syakantu G
PLoS One; 2014; 9(3):e90991. PubMed ID: 24604067
[TBL] [Abstract][Full Text] [Related]
10. Evidence on the cost-effectiveness of lifelong antiretroviral therapy for prevention of mother-to-child transmission of HIV: implications for resource-limited countries in sub-Saharan Africa.
Ngambi PG; Kalungia AC; Law MR; Kalemeera F; Truter I; Godman B; Munkombwe D
Expert Rev Pharmacoecon Outcomes Res; 2017 Oct; 17(5):459-467. PubMed ID: 28770641
[TBL] [Abstract][Full Text] [Related]
11. The incremental cost of switching from Option B to Option B+ for the prevention of mother-to-child transmission of HIV.
O'Brien L; Shaffer N; Sangrujee N; Abimbola TO
Bull World Health Organ; 2014 Mar; 92(3):162-70. PubMed ID: 24700975
[TBL] [Abstract][Full Text] [Related]
12. Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.
Myer L; Phillips TK; Zerbe A; Brittain K; Lesosky M; Hsiao NY; Remien RH; Mellins CA; McIntyre JA; Abrams EJ
PLoS Med; 2018 Mar; 15(3):e1002547. PubMed ID: 29601570
[TBL] [Abstract][Full Text] [Related]
13. The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis.
Dunning L; Francke JA; Mallampati D; MacLean RL; Penazzato M; Hou T; Myer L; Abrams EJ; Walensky RP; Leroy V; Freedberg KA; Ciaranello A
PLoS Med; 2017 Nov; 14(11):e1002446. PubMed ID: 29161262
[TBL] [Abstract][Full Text] [Related]
14. Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi.
Tweya H; Keiser O; Haas AD; Tenthani L; Phiri S; Egger M; Estill J
AIDS; 2016 Mar; 30(6):953-62. PubMed ID: 26691682
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.
Price JT; Wheeler SB; Stranix-Chibanda L; Hosek SG; Watts DH; Siberry GK; Spiegel HM; Stringer JS; Chi BH
J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 2(Suppl 2):S145-53. PubMed ID: 27355502
[TBL] [Abstract][Full Text] [Related]
16. Optimizing HIV retesting during pregnancy and postpartum in four countries: a cost-effectiveness analysis.
Meisner J; Roberts DA; Rodriguez P; Sharma M; Newman Owiredu M; Gomez B; de Mello MB; Bobrik A; Vodianyk A; Storey A; Githuka G; Chidarikire T; Barnabas R; Farid S; Essajee S; Jamil MS; Baggaley R; Johnson C; Drake AL
J Int AIDS Soc; 2021 Apr; 24(4):e25686. PubMed ID: 33787064
[TBL] [Abstract][Full Text] [Related]
17. Breastfeeding by HIV-1-infected women and outcome in their infants: a cohort study from Durban, South Africa.
Bobat R; Moodley D; Coutsoudis A; Coovadia H
AIDS; 1997 Nov; 11(13):1627-33. PubMed ID: 9365768
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settings.
Dugdale CM; Ufio O; Alba C; Permar SR; Stranix-Chibanda L; Cunningham CK; Fouda GG; Myer L; Weinstein MC; Leroy V; McFarland EJ; Freedberg KA; Ciaranello AL
J Int AIDS Soc; 2023 Jan; 26(1):e26052. PubMed ID: 36604316
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
20. Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges.
Kesho Bora Study Group
Contemp Clin Trials; 2011 Jan; 32(1):74-85. PubMed ID: 20854932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
